Byrne Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.86K Buy
+16
New +$3.5K ﹤0.01% 523
2024
Q2
Sell
-9
Closed -$1.08K 546
2024
Q1
$1.08K Sell
9
-22
-71% -$2.69K ﹤0.01% 512
2023
Q4
$3.79K Sell
31
-15
-33% -$1.87K ﹤0.01% 447
2023
Q3
$6K Hold
46
0.01% 384
2023
Q2
$6K Hold
46
﹤0.01% 449
2023
Q1
$7K Hold
46
0.01% 424
2022
Q4
$7.33K Sell
46
-10
-18% -$1.47K 0.01% 409
2022
Q3
$7K Sell
56
-50
-47% -$7.6K 0.01% 379
2022
Q2
$17K Sell
106
-74
-41% -$11.4K 0.01% 302
2022
Q1
$28K Hold
180
0.02% 267
2021
Q4
$23K Buy
+180
New +$23.7K 0.01% 279

Other funds holding JAZZ